General Catalyst Group Management, LLC Diversified Active

Name: General Catalyst Group Management, LLC Q2 2026 13F Filing | 13F Explorer
Creator: General Catalyst Group Management, LLC
Published: 2026-08-17

Location: Cambridge, MA

CIK: 0001637946 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 17, 2026

Total Value: $189M (100.0% shares, 0.0% debt)

Holdings (14)

New Positions (4)

PBLS Parabilis Medicines, Inc. 23.2%

Value $43.82M Shares 1,600,937 Est. Cost $27.37 Unrealized —

ODTX Odyssey Therapeutics, Inc. 8.0%

Value $15.16M Shares 810,272 Est. Cost $18.71 Unrealized —

DASH Doordash Inc. 0.3%

Value $526K Shares 2,850 Est. Cost $184.53 Unrealized —

CVNA Carvana Co 0.2%

Value $426K Shares 6,465 Est. Cost $65.82 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
PBLS	Parabilis Medicines, Inc.	1,600,937	$43.82M	23.2%	$27.37	—	COM	698955101
ODTX	Odyssey Therapeutics, Inc.	810,272	$15.16M	8.0%	$18.71	—	COMMON STOCK	67613T104
DASH	Doordash Inc.	2,850	$526K	0.3%	$184.53	—	CL A	25809K105
CVNA	Carvana Co	6,465	$426K	0.2%	$65.82	—	CL A	146869102

Increased Positions (3)

AMZN Amazon.com Inc. 0.5%

Value $925K (+72.1%) Shares 3,882 (+50.3%) Est. Cost $230.69 Unrealized —

META Meta Platforms Inc. 0.4%

Value $744K (+97.5%) Shares 1,320 (+100.6%) Est. Cost $609.29 Unrealized —

CPNG Coupang Inc. 0.5%

Value $950K (+37.2%) Shares 54,677 (+49.1%) Est. Cost $19.04 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
AMZN	Amazon.com Inc.	3,882 (+50.3%)	$925K (+72.1%)	0.5%	$230.69	—	COM	023135106
META	Meta Platforms Inc.	1,320 (+100.6%)	$744K (+97.5%)	0.4%	$609.29	—	CL A	30303M102
CPNG	Coupang Inc.	54,677 (+49.1%)	$950K (+37.2%)	0.5%	$19.04	—	CL A	22266T109

Exited Positions (2)

IOT SAMSARA INC 33.6%

Value $63.38M Shares 2,000,000 Est. Cost $26.05 Unrealized —

GTLB GITLAB INC 10.6%

Value $19.94M Shares 921,405 Est. Cost $102.34 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
IOT	SAMSARA INC	2,000,000	$63.38M	33.6%	$26.05	—	—	79589L106
GTLB	GITLAB INC	921,405	$19.94M	10.6%	$102.34	—	—	37637K108

Unchanged Positions (7)

AVBP ArriVent BioPharma, Inc. 27.5%

Value $51.93M Shares 1,494,786 Est. Cost $20.17 Unrealized —

CART Maplebear, Inc. 17.9%

Value $33.65M Shares 710,711 Est. Cost $30.31 Unrealized —

GUTS Fractyl Health, Inc. 2.1%

Value $3.88M Shares 4,884,186 Est. Cost $1.62 Unrealized —

EIKN Eikon Therapeutics, Inc. 2.1%

Value $3.983M Shares 305,233 Est. Cost $10.58 Unrealized —

LIFE Ethos Technologies, Inc. 0.7%

Value $1.346M Shares 74,179 Est. Cost $11.17 Unrealized —

FIG Figma, Inc. 0.1%

Value $269K Shares 14,845 Est. Cost $68.66 Unrealized —

MAZE Maze Therapeutics, Inc. 16.4%

Value $30.91M Shares 1,035,910 Est. Cost $12.04 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
AVBP	ArriVent BioPharma, Inc.	1,494,786	$51.93M	27.5%	$20.17	—	COM	04272N102
CART	Maplebear, Inc.	710,711	$33.65M	17.9%	$30.31	—	COM	565394103
GUTS	Fractyl Health, Inc.	4,884,186	$3.88M	2.1%	$1.62	—	COM	35168W103
EIKN	Eikon Therapeutics, Inc.	305,233	$3.983M	2.1%	$10.58	—	COM	282564103
LIFE	Ethos Technologies, Inc.	74,179	$1.346M	0.7%	$11.17	—	CL A	29765A101
FIG	Figma, Inc.	14,845	$269K	0.1%	$68.66	—	CLASS A COM STK	316841105
MAZE	Maze Therapeutics, Inc.	1,035,910	$30.91M	16.4%	$12.04	—	COM	578784100